Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios Charalampopoulos

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
International Journal of Cardiology|September 21, 2022
Atrial flutter and fibrillation in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension in the ASPIRE registry: Comparison of rate versus rhythm control approachesMark Anthony Sammut, Robin Condliffe, Charlie Elliot, et al.
The European Respiratory Journal|February 29, 2020
Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertensionRobert A Lewis, A A Roger Thompson, Catherine G Billings, et al.
Annals of the American Thoracic Society|October 15, 2024
Do Hemodynamic Definitions of Chronic Thromboembolic Pulmonary Hypertension Distinguish between Distinct Phenotypes of Chronic Thromboembolic Pulmonary Disease?Ellis Cerrone, Abdul G Hameed, David G Kiely, et al.
Frontiers in Medicine|July 7, 2018
Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class ICatherine G Billings, Robert Lewis, Iain J Armstrong, et al.
Pulmonary Circulation|May 4, 2022
Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertensionMikaela Wardle, Amanda Nair, Sarah Saunders, et al.
Frontiers in Cardiovascular Medicine|May 4, 2023
Non-invasive detection of severe PH in lung disease using magnetic resonance imagingDheyaa Alkhanfar, Krit Dwivedi, Faisal Alandejani, et al.
The International Journal of Cardiovascular Imaging|May 12, 2021
Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fractionPankaj Garg, Robert A Lewis, Christopher S Johns, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 6, 2017
Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertensionCatherine G Billings, Judith A Hurdman, Robin Condliffe, et al.
Pulmonary Circulation|April 19, 2019
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE RegistryCatherine G Billings, Robert Lewis, Judith A Hurdman, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2024
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Cardiology|September 21, 2022
Atrial flutter and fibrillation in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension in the ASPIRE registry: Comparison of rate versus rhythm control approachesMark Anthony Sammut, Robin Condliffe, Charlie Elliot, et al.
The European Respiratory Journal|February 29, 2020
Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertensionRobert A Lewis, A A Roger Thompson, Catherine G Billings, et al.
Annals of the American Thoracic Society|October 15, 2024
Do Hemodynamic Definitions of Chronic Thromboembolic Pulmonary Hypertension Distinguish between Distinct Phenotypes of Chronic Thromboembolic Pulmonary Disease?Ellis Cerrone, Abdul G Hameed, David G Kiely, et al.
Frontiers in Medicine|July 7, 2018
Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class ICatherine G Billings, Robert Lewis, Iain J Armstrong, et al.
Pulmonary Circulation|May 4, 2022
Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertensionMikaela Wardle, Amanda Nair, Sarah Saunders, et al.
Frontiers in Cardiovascular Medicine|May 4, 2023
Non-invasive detection of severe PH in lung disease using magnetic resonance imagingDheyaa Alkhanfar, Krit Dwivedi, Faisal Alandejani, et al.
The International Journal of Cardiovascular Imaging|May 12, 2021
Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fractionPankaj Garg, Robert A Lewis, Christopher S Johns, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 6, 2017
Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertensionCatherine G Billings, Judith A Hurdman, Robin Condliffe, et al.
Pulmonary Circulation|April 19, 2019
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE RegistryCatherine G Billings, Robert Lewis, Judith A Hurdman, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2024
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
Pageof 6